NKTR-102 Scientific and Clinical Data Presentations
Data Presentation from 2008 EORTC-NCI-AACR Symposium - October 23, 2008
- Press Release: Significant Anti-Tumor Activity and Extended Half-Life of NKTR-102 (PEG-irinotecan) Highlighted in Phase 1 Data Presented at EORTC-NCI-AACR Symposium
- Poster #595: First Phase I Trial of NKTR-102 (PEG-irinotecan) Reveals Early Evidence of Broad Anti-Tumor Activity in Three Different Schedules - Authors: D.D. Von Hoff, G.S. Jameson, M.J. Borad, L.S. Rosen, J. Utz, M. Basche, C. Alemany, S. Dhar, L. Acosta, T. Barker, J. Walling, J.T. Hamm.
Data presentation from ASCO Annual Meeting - June 2, 2008
Data Presentations from AACR 2008 - April 14, 2008
Data Presentations from 2007 AACR-NCI-EORTC International Conference - October 25, 2007
Data Presentations from ECCO 14 Conference - September 27, 2007